Protocol Ledger

NCT03288532 · Phase III · RECRUITING

Renal Adjuvant MultiPle Arm Randomised Trial

Interventional Phase III clinical trial protocol NCT03288532 sponsored by University College, London in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2018-07-19 Enrollment: 1,750 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT03288532
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)1,750 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)0 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT03288532
Protocol FieldVerified Registry Value
NCT IdentifierNCT03288532
Consolidated Lead SponsorUniversity College, London
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment1,750 participants (ESTIMATED)
Registered Start Date2018-07-19
WhyStopped ClassificationNot Stopped

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI